HDAC9 and neoplasm: For instance, entinostat (formally MS-275, Syndax Pharmaceuticals, Inc, Waltham, MA) is an ideal example of class I HDAC inhibitor which possesses the ability to reduce the proliferation of cancer cells and tumor xenografts in various cancer types while exhibiting mild toxicity to normal cells (129).